Rafferty Asset Management
MIRM icon

Rafferty Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Rafferty Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Sell
29,366
-19,794
-40% -$1.99M 0.01% 492
2026
Q1 		$4.54M Sell
49,160
-23,783
-33% -$2.24M 0.02% 418
2025
Q4 		$5.76M Buy
72,943
+39,816
+120% +$2.86M 0.02% 394
2025
Q3 		$2.43M Sell
33,127
-4,080
-11% -$259K 0.01% 604
2025
Q2 		$1.89M Sell
37,207
-14,650
-28% -$652K 0.01% 617
2025
Q1 		$2.34M Buy
51,857
+6,697
+15% +$316K 0.01% 534
2024
Q4 		$1.87M Sell
45,160
-40,297
-47% -$1.68M 0.01% 665
2024
Q3 		$3.33M Buy
85,457
+16,599
+24% +$662K 0.01% 505
2024
Q2 		$2.35M Sell
68,858
-197,404
-74% -$5.18M 0.01% 602
2024
Q1 		$6.69M Buy
266,262
+135,916
+104% +$3.74M 0.03% 392
2023
Q4 		$3.85M Sell
130,346
-6,859
-5% -$208K 0.02% 503
2023
Q3 		$4.34M Buy
137,205
+21,312
+18% +$584K 0.03% 421
2023
Q2 		$3M Buy
115,893
+29,732
+35% +$791K 0.02% 529
2023
Q1 		$2.07M Sell
86,161
-60,083
-41% -$1.37M 0.01% 603
2022
Q4 		$2.85M Buy
146,244
+87,697
+150% +$1.73M 0.02% 496
2022
Q3 		$1.23M Buy
+58,547
New +$1.41M 0.01% 616

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rafferty Asset Management's MIRM Position: Q2 2026 in Review

Rafferty Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 40% in Q2 2026, selling an estimated $1.99M and leaving 29,366 shares worth $3.44M. The position accounts for 0.01% of the portfolio, ranked #492.

Rafferty Asset Management first reported a position in MIRM in Q3 2022 and has held it in 16 quarters since. The position peaked at $6.69M in Q1 2024. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Rafferty Asset Management held 29,366 shares of Mirum Pharmaceuticals worth $3.44M as of Q2 2026.
  • Rafferty Asset Management sold 19,794 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.99M.
  • Mirum Pharmaceuticals made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #492 holding.
  • Rafferty Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Rafferty Asset Management's Mirum Pharmaceuticals position peaked at $6.69M in Q1 2024.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.